Novella Clinical Taps Medidata Solutions for Additional Insight into Clinical Research Costs
Medidata Solutions announced that Novella Clinical has expanded its use of Medidata products with the addition of Medidata Grants Manager®, the investigator site benchmarking tool. Grants Manager offers Novella a clear competitive advantage by enabling access to critical cost data to more accurately forecast trial costs as it serves sponsors outsourcing clinical trial activities. Grants Manager is designed to help users streamline site budget negotiations, ensure fair and reliable investigator payments, mitigate compliance risks, and reduce time of site enrollment.
Novella first partnered with Medidata in 2005 when it adopted Medidata Rave®, a system for electronic data capture, management, and analysis. Now, with the adoption of Grants Manager, Novella has access to Medidata’s unique PICAS® database—a clinical cost database derived from negotiated agreements between sponsors, investigators and CROs—which will bring insight into industry-benchmarked investigator site costs. Grants Manager offers access to data from nearly a quarter million grants and contracts and more than 27,000 protocols in over 1,400 indications.
As a Medidata Services Partner, Novella is accredited in Medidata Rave to provide a full suite of Rave-related services, including end-user training, user and site administration, study build, reporting, outputs, integrations, and migrations. The addition of Grants Manager into Novella’s clinical systems environment further enables it to provide services that streamline and enhance its customers’ clinical trials.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Landmark Phase III Trial Shows Keytruda Significantly Improves Event-Free Survival in LA-HNSCC
April 28th 2025Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or recurrence in resectable, locally advanced head and neck squamous cell carcinoma, marking the first major clinical advance for this patient population in more than two decades.
